Sakar Healthcare (SAKAR) — Financial Results

Sakar Healthcare reported Q4 FY26 revenue of ₹7,109.70 lakhs, up 42% YoY, with EBITDA at ₹2,623.57 lakhs (+67% YoY) and PAT at ₹1,102.43 lakhs (+91% YoY). Oncology exports contributed 38% of total revenue, reaching INR30 lakhs in Q4 (up from INR22 lakhs YoY), while domestic oncology revenue stood at INR31 crores. Management reaffirmed FY27 revenue growth of ~40% (INR380 crores) and projected oncology exports to generate INR50-100 crores over two years, targeting INR500 crores total revenue with oncology contributing 60%.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SAKAR ✨ Ask AI About This

About Sakar Healthcare Limited (SAKAR)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,550.15 Cr P/E: 102.3

View full SAKAR stock details →

📡 Get AI alerts when SAKAR files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SAKAR — Free

💡 Ask AI about this filing

"How does this financial results affect Sakar Healthcare Limited's outlook?" "What did Sakar Healthcare Limited announce on 22 May 2026?" "Is this positive or negative for SAKAR?"

Ask AI Free →

📊 More SAKAR filings

See all SAKAR filings →

🔥 Also filed on 22 May 2026

PWL Physicswallah Limited Announcement PRAKASH Prakash Industries Limited Corporate Action PROSTARM Prostarm Info Systems Limited Financial Results PRAKASH Prakash Industries Limited Financial Results PWL Physicswallah Limited Financial Results RAMCOCEM The Ramco Cements Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SAKAR files new disclosures

Track SAKAR filings, board meetings, and corporate actions. Free email alerts at 5 PM.